- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 397826, 6 pages
Study of the Association between ITPKC Genetic Polymorphisms and Calcium Nephrolithiasis
1Department of Nephrology, Chi-Mei Medical Center, Tainan 710, Taiwan
2Medical Laboratory Science and Biotechnology, Chung Hwa University of Medical Technology, Tainan 717, Taiwan
3Department of Urology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4Department of Clinical Pharmacy, Taipei Medical University, Taipei 110, Taiwan
5Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
6Department of Clinical Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
7Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, Taipei 110, Taiwan
8Department of Pharmacy, Taipei Medical University, Wanfang Hospital, Taipei 116, Taiwan
Received 26 November 2013; Accepted 15 January 2014; Published 3 March 2014
Academic Editor: Shuen-Iu Hung
Copyright © 2014 Wei-Chih Kan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Y.-H. Lee, W.-C. Huang, J.-Y. Tsai et al., “Epidemiological studies on the prevalence of upper urinary calculi in Taiwan,” Urologia Internationalis, vol. 68, no. 3, pp. 172–177, 2002.
- C. Y. C. Pak, “Kidney stones,” The Lancet, vol. 351, no. 9118, pp. 1797–1801, 1998.
- A. Basiri, N. Shakhssalim, A. R. Khoshdel et al., “Familial relations and recurrence pattern in nephrolithiasis: new words about old subjects,” Urology Journal, vol. 7, no. 2, pp. 81–86, 2010.
- M. J. Semins, A. D. Shore, M. A. Makary, T. Magnuson, R. Johns, and B. R. Matlaga, “The association of increasing body mass index and kidney stone disease,” Journal of Urology, vol. 183, no. 2, pp. 571–575, 2010.
- D. R. Basavaraj, C. S. Biyani, A. J. Browning, and J. J. Cartledge, “The role of urinary kidney stone inhibitors and promoters in the pathogenesis of Calcium containing renal stones,” EAU-EBU Update Series, vol. 5, no. 3, pp. 126–136, 2007.
- W. G. Robertson, M. Peacock, and B. E. C. Nordin, “Calcium crystalluria in recurrent renal-stone formers,” The Lancet, vol. 2, no. 7610, pp. 21–24, 1969.
- M. W. Bigelow, J. H. Wiessner, J. G. Kleinman, and N. S. Mandel, “Calcium oxalate-crystal membrane interactions: dependence on membrane lipid composition,” Journal of Urology, vol. 155, no. 3, pp. 1094–1098, 1996.
- S. R. Khan and D. J. Kok, “Modulators of urinary stone formation,” Frontiers in Bioscience, vol. 9, pp. 1450–1482, 2004.
- Y.-H. Chou, S.-H. H. Juo, Y.-C. Chiu et al., “A polymorphism of the ORAI1 gene is associated with the risk and recurrence of calcium nephrolithiasis,” Journal of Urology, vol. 185, no. 5, pp. 1742–1746, 2011.
- K. Sauer and M. P. Cooke, “Regulation of immune cell development through soluble inositol-1,3,4,5- tetrakisphosphate,” Nature Reviews Immunology, vol. 10, no. 4, pp. 257–271, 2010.
- Y. Onouchi, T. Gunji, J. C. Burns et al., “ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms,” Nature Genetics, vol. 40, no. 1, pp. 35–42, 2008.
- K. D. Yang, J.-C. Chang, H. Chuang et al., “Gene-gene and gene-environment interactions on IgE production in prenatal stage,” Allergy, vol. 65, no. 6, pp. 731–739, 2010.
- W. L. Hsu, M. H. Tsai, M. W. Lin, et al., “Differential effects of arsenic on calcium signaling in primary keratinocytes and malignant (HSC-1) cells,” Cell Calcium, vol. 52, no. 2, pp. 161–169, 2012.
- G. Gambaro, S. Favaro, and A. D'Angelo, “Risk for renal failure in nephrolithiasis,” American Journal of Kidney Diseases, vol. 37, no. 2, pp. 233–243, 2001.
- D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976.
- A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999.
- N. Johri, B. Cooper, W. Robertson, S. Choong, D. Rickards, and R. Unwin, “An update and practical guide to renal stone management,” Nephron, vol. 116, no. 3, pp. c159–c171, 2010.
- S. R. Mulay, A. Evan, and H. J. Anders, “Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease,” in Nephrology, Dialysis, Transplantation, European Renal Association, 2013.
- J. A. Sayer, “Renal stone disease,” Nephron, vol. 118, no. 1, pp. p35–p44, 2011.
- G. Thorleifsson, H. Holm, V. Edvardsson et al., “Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density,” Nature Genetics, vol. 41, no. 8, pp. 926–930, 2009.
- L. G. Ferreira, A. C. Pereira, and I. P. Heilberg, “Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients,” Nephron, vol. 114, no. 2, pp. c135–c144, 2010.
- J. E. Zerwekh, M. R. Hughes, B. Y. Reed et al., “Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 10, pp. 2960–2965, 1995.
- S. Nishio, M. Hatanaka, H. Takeda, T. Iseda, H. Iwata, and M. Yokoyama, “Analysis of urinary concentrations of calcium phosphate crystal- associated proteins: α2-HS-glycoprotein, prothrombin F1, and osteopontin,” Journal of the American Society of Nephrology, vol. 10, supplement 14, pp. S394–S396, 1999.
- A. Braun, D. Varga-Szabo, C. Kleinschnitz et al., “Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation,” Blood, vol. 113, no. 9, pp. 2056–2063, 2009.
- W.-C. Chang and A. B. Parekh, “Close functional coupling between Ca2+ release-activated Ca2+ channels, arachidonic acid release, and leukotriene C4 secretion,” The Journal of Biological Chemistry, vol. 279, no. 29, pp. 29994–29999, 2004.
- H.-C. Kuo and W.-C. Chang, “Genetic polymorphisms in Kawasaki disease,” Acta Pharmacologica Sinica, vol. 32, no. 10, pp. 1193–1198, 2011.